Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this non-interventional study is the collection and documentation of data on
safety and efficacy of intravenous (IV) bevacizumab (Avastin) in addition to platinum-based
chemotherapy for first-line treatment in participants with unresectable advanced, metastatic
or recurrent non-small cell lung cancer (NSCLC) other than predominantly squamous cell
histology with focus on adenocarcinoma and elderly patients in daily routine.